Kongyuan Wei

659 citations
24 papers · 333 indexed · h-index 9
Topics
Pancreatic and Hepatic Oncology Research (12 papers)Pancreatitis Pathology and Treatment (8 papers)Neuroendocrine Tumor Research Advances (7 papers)
Partner nations
ChinaGermanyPhilippines

In The Last Decade

Kongyuan Wei

20 papers receiving 331 citations

Peers

Kongyuan Wei
Comparison fields: 5 of 53
  • Oncology 193
  • Pulmonary and Respiratory Medicine 120
  • Surgery 109
  • Cancer Research 84
  • Molecular Biology 81
Replace Niko Kemi with:
Niko Kemi Finland
Justin A. Drake United States
Tatsuki Nanami Japan
Masayuki Urabe Japan
Alexandre Rouquette France
Fabio Catalano Italy
Shawn Steen United States
Brent K. Larson United States
Virginia Palomar Coloma France
Elisa Andrini Italy
Kongyuan Wei relative to Niko Kemi Finland Niko Kemi's profile →
Citations per field
00.5×1.5×2.4×
Niko Kemi · 1×
Citations per year

Countries citing papers authored by Kongyuan Wei

Since Specialization
Citations

This map shows the geographic impact of Kongyuan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kongyuan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kongyuan Wei more than expected).

Fields of papers citing papers by Kongyuan Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kongyuan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kongyuan Wei. The network helps show where Kongyuan Wei may publish in the future.

Co-authorship network of co-authors of Kongyuan Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Kongyuan Wei. A scholar is included among the top collaborators of Kongyuan Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kongyuan Wei. Kongyuan Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 0
5 4
6 7
7 5
8 1
9 2
10 17
11 2
12 57
13 1
14 57
15 23
16 24
17 10
18 39
19 5
20 6

About Kongyuan Wei

Kongyuan Wei is a scholar working on Oncology, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 333 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (12 papers), Pancreatitis Pathology and Treatment (8 papers) and Neuroendocrine Tumor Research Advances (7 papers). The work is most often cited by research in Oncology (193 citations), Cancer Research (84 citations) and Pulmonary and Respiratory Medicine (120 citations). Kongyuan Wei has collaborated with scholars based in China, Germany and Philippines. Frequent co-authors include Thilo Hackert, Hao Chi, Xiaosong Li, Zhijia Xia, Yue Zhao, Wenbo Meng, Yuan Yang, Zengwei Tang, Xun� Li and Pengpeng Zhang. Their work appears in journals such as Frontiers in Immunology, Medicine and Annals of Surgical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026